Human monocyte-macrophage-CSF preparations
AssigneeMorinaga Milk Industry Co., Ltd.
InventorsTakuji Kawashima, Nobuya Yanai, Muneo Yamada, Hajime Yokota, Kunio Ujiie, Katsuo Yoshida, Shinya Suzu, Fumimaro Takaku, Kazuo Motoyoshi, Nobuhiro Yamada
Life of this patent
Estimating the term…
Abstract
Human M-CSF preparations and recombinant human M-CSF preparations against myelodysplastic syndrome, malignant tumor and hyperlipemia and auxiliary therapeutic preparations to be dosed along with platinum-complex anticancer preparations.
Claims8
A method of treating myelodysplastic syndrome, comprising administering to a person in need thereof an effective amount of naturally-occurring human monocyte-macrophage colony stimulating factor.
A method of decreasing myeloblast count in peripheral blood and for decreasing the proportion of myeloblasts to total bone marrow cells while increasing erythrocyte, leukocyte and neutrophil leukocyte counts in peripheral blood, comprising administering to a patient having myelodysplastic syndrome an effective amount of naturally-occurring human monocyte-macrophage colony stimulating factor.
Dependencies are inferred from the claim text.